Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-transplant Complications

Successful rescue of early graft failure in pediatric patients using T-cell-depleted haploidentical hematopoietic SCT

Bone Marrow Transplantation volume 49, pages 270–275 (2014)Cite this article

Subjects

Abstract

Graft failure (GF) is a significant complication after allogeneic hematopoietic stem cell transplantation (HCT) and is associated with a high mortality rate. We performed re-transplantation using haploidentical-related donors to rescue children with early GF. Between 2008 and 2013, 10 patients received re-transplantation from haploidentical family donors. The median age at HCT was 13.5 years and the median time between transplantations was 52.5 days. Conditioning regimen with fludarabine and CY was used in seven patients, and TBI was added in three patients. All 10 patients received T-cell-depleted grafts using CD3 or CD3/CD19 MoAb. The median numbers of CD34+ and CD3+ cells were 5.52 × 106/kg and 1.08 × 106/kg, respectively. For GVHD prophylaxis, mycophenolate mofetil (MMF) and tacrolimus or MMF and CYA were used. All 10 patients achieved a sustained neutrophil engraftment and maintained a complete donor chimerism at the time of analysis (median 23 months, range 6–62 months). Nine of 10 patients were alive, and one patient with moyamoya disease with AML died of encephalopathy 7 months post transplant. This study suggests that fludarabine- and CY-based conditioning with T-cell-depleted haploidentical HCT is a feasible option to rescue pediatric patients with primary GF.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med 1989; 320: 197–204.

    Article  CAS  PubMed  Google Scholar 

  2. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New Engl J Med 2004; 3512: 2265–2275.

    Article  Google Scholar 

  3. Powles RL, Morgenstern GR, Kay HE, McElwain TJ, Clink HM, Dady PJ et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1983; 12: 612–615.

    Article  Google Scholar 

  4. Davies SM, Weisdorf DJ, Haake RJ, Kersey JH, McGlave PB, Ramsay NK et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 141: 73–77.

    Google Scholar 

  5. Waki F, Masuoka K, Fukuda T, Kanda Y, Nakamae M, Yakushijin K et al. Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. Biol Blood Marrow Transplant 2011; 17: 841–851.

    Article  PubMed  Google Scholar 

  6. Yoshihara S, Ikegame K, Taniguchi K, Kaida K, Kim EH, Nakata J et al. Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning. Bone Marrow Transplant 2012; 47: 369–373.

    Article  CAS  PubMed  Google Scholar 

  7. Lang P, Mueller I, Greil J, Bader P, Schumm M, Pfeiffer M et al. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cell Mol Dis 2008; 403: 33–39.

    Article  Google Scholar 

  8. Im HJ, Koh KN, Choi ES, Jang S, Kwon SW, Park CJ et al. Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia. Biol Blood Marrow Transplant 2013; 19: 754–759.

    Article  PubMed  Google Scholar 

  9. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  10. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  11. Doney KC, Weiden PL, Storb R, Thomas ED . Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 1981; 11: 1–8.

    Article  CAS  PubMed  Google Scholar 

  12. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983; 98: 461–466.

    Article  CAS  PubMed  Google Scholar 

  13. Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M et al. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol 2000; 111: 292–302.

    Article  CAS  PubMed  Google Scholar 

  14. Bethge WA, Haegele M, Faul C, Lang P, Schumm M, Bornhauser M et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. Exp Hematol 2006; 34: 1746–1752.

    Article  CAS  PubMed  Google Scholar 

  15. Muller S, Schulz A, Reiss U, Schwarz K, Schreiner T, Wiesneth M et al. Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children. Bone Marrow Transplant 1999; 24: 575–581.

    Article  CAS  PubMed  Google Scholar 

  16. Chan KW, Grimley MS, Taylor C, Wall DA . Early identification and management of graft failure after unrelated cord blood transplantation. Bone Marrow Transplant 2008; 42: 35–41.

    Article  CAS  PubMed  Google Scholar 

  17. Grandage VL, Cornish JM, Pamphilon DH, Potter MN, Steward CG, Oakhill A et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation. Bone Marrow Transplant 1998; 21: 687–690.

    Article  CAS  PubMed  Google Scholar 

  18. Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006; 12: 1073–1084.

    Article  PubMed  Google Scholar 

  19. Storb R, Pepe M, Anasetti C, Appelbaum FR, Beatty P, Doney K et al. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 1990; 76: 1037–1045.

    CAS  PubMed  Google Scholar 

  20. Huo MR, Xu LP, Li D, Liu DH, Liu KY, Chen H et al. The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation. Clin Transplant 2012; 26: 284–291.

    Article  PubMed  Google Scholar 

  21. Fleischhauer K, Zino E, Mazzi B, Sironi E, Servida P, Zappone E et al. Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901. Blood 2001; 98: 1122–1126.

    Article  CAS  PubMed  Google Scholar 

  22. Wolff SN . Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29: 545–552.

    Article  CAS  PubMed  Google Scholar 

  23. Kato M, Matsumoto K, Suzuki R, Yabe H, Inoue M, Kigasawa H et al. Salvage allogeneic hematopoietic SCT for primary graft failure in children. Bone Marrow Transplant 2013; 48: 1173–1178.

    Article  CAS  PubMed  Google Scholar 

  24. Martin PJ, Akatsuka Y, Hahne M, Sale G . Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 1998; 92: 2177–2181.

    CAS  PubMed  Google Scholar 

  25. Westerhuis G, Maas WG, Willemze R, Toes RE, Fibbe WE . Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 2005; 106: 2215–2220.

    Article  CAS  PubMed  Google Scholar 

  26. Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009; 88: 1019–1024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ciurea SO, Thall PF, Wang X, Wang SA, Hu Y, Cano P et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 2011; 118: 5957–5964.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Jabbour E, Rondon G, Anderlini P, Giralt SA, Couriel DR, Champlin RE et al. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. Bone Marrow Transplant 2007; 40: 431–435.

    Article  CAS  PubMed  Google Scholar 

  29. Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN et al. Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant 2007; 13: 1313–1323.

    Article  CAS  PubMed  Google Scholar 

  30. McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 1994; 13: 233–237.

    CAS  PubMed  Google Scholar 

  31. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108: 1485–1491.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. New Engl J Med 2004; 351: 2276–2285.

    Article  CAS  PubMed  Google Scholar 

  33. Jacobson CA, Turki AT, McDonough SM, Stevenson KE, Kim HT, Kao G et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 565–574.

    Article  CAS  PubMed  Google Scholar 

  34. Bunin N, Small T, Szabolcs P, Baker KS, Pulsipher MA, Torgerson T . NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors. Biol Blood Marrow Transplant 2012; 18: 6–15.

    Article  PubMed  Google Scholar 

  35. Eyrich M, Lang P, Lal S, Bader P, Handgretinger R, Klingebiel T et al. A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors. Br J Haematol 2001; 114: 422–432.

    Article  CAS  PubMed  Google Scholar 

  36. Meijer E, Slaper-Cortenbach IC, Thijsen SF, Dekker AW, Verdonck LF . Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant 2002; 29: 335–339.

    Article  CAS  PubMed  Google Scholar 

  37. Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM, Sobocinski KA et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 4992–5001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant (2011–0571) from the Asan Institute for Life Sciences, Seoul, Korea.

Author information

Author notes

  1. J A Park and K N Koh: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Pediatrics, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea

    J A Park

  2. Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children’s Hospital, Seoul, Korea

    K N Koh, E S Choi, J J Seo & H J Im

  3. Department of Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center Children’s Hospital, Seoul, Korea

    S Jang, S W Kwon & C-J Park

Authors
  1. J A Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K N Koh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E S Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S W Kwon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C-J Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J J Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H J Im
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H J Im.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, J., Koh, K., Choi, E. et al. Successful rescue of early graft failure in pediatric patients using T-cell-depleted haploidentical hematopoietic SCT. Bone Marrow Transplant 49, 270–275 (2014). https://doi.org/10.1038/bmt.2013.163

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.163

Keywords

This article is cited by

Search

Advanced search

Quick links